NC Respiratory Illness Vaccination Data Dashboards
The dashboards on this page show how many flu, COVID-19 and RSV (adult and pediatric) doses are administered in NC, and the estimated percentage of North Carolinians who are immunized.
For more information on respiratory vaccines, please visit the Vaccine Information page.
Vaccination Data on This Page
Active Dashboards
Archived Dashboards
Understanding These Dashboards
This page shows doses administered and reported in the North Carolina Immunization Registry (NCIR).
Doses Administered: Includes any dose reported in NCIR with a vaccination date within the selected or noted vaccination season.
Individuals Vaccinated: Represents people with at least one dose of vaccine during the vaccination season selected or noted.
Estimated Coverage*: Vaccination coverage is calculated as the estimated percentage of the population that has been appropriately immunized.
*Calculated with administrations only reported to NCIR.
COVID-19
Data on this dashboard reflects COVID-19 vaccine administrations since August 2023.
For data before 2023, visit (Archived) COVID-19 Vaccinations.
Adult RSV
Eligible Age Groups
- Everyone aged 75+
- 50-74-year-olds* who are at increased risk** of severe RSV disease
*The eligibility criteria changed in August 2025 from 60-74-year-olds to 50-74-year-olds at increased risk.
**Visit CDC's RSV Vaccines for Adults page for more increased risk criteria.
Note: Adult RSV is not currently an annual vaccine, therefore, estimated coverage and individuals vaccinated include any dose recorded since 2023 and is not reported on a seasonal basis.
Pediatric/Maternal RSV
RSV (Respiratory Syncytial Virus) is the leading cause of infant hospitalization. The RSV Immunization can help protect infants from getting very sick from RSV.
This dashboard shows RSV maternal and pediatric (ages under 8 months) doses reported in NCIR from September 2025 through April 30, 2026.
2025-26 Pediatric and Maternal RSV Recommendations
RSV immunization is recommended for everyone who was pregnant from September through January during 32-36 weeks of pregnancy.
Only one dose of the maternal RSV vaccine for a pregnant person is recommended. If a mother received the vaccine in a previous pregnancy, she should not get another dose in a future pregnancy.
RSV immunization is recommended for all infants who were less than 8 months old from October through March, and if their mother did not receive RSV vaccine during pregnancy.
Some children 8-19 months old who are at increased risk for severe RSV illness are eligible to receive monoclonal antibodies but are not included in the dashboard visualizations. Additional doses were administered during the 2024-2025 season to children between 8-19-months old who are considered high risk to severe RSV. Visit the CDC's RSV Infants and Young Children page for increased risk criteria.
For more information: Check the CDC's "Who Can Receive RSV Immunization?" chart